Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Delcath Systems Inc (DCTH)

Surgical & Medical Instruments & Apparatus

https://www.delcath.com

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

1633 BROADWAY, SUITE 22C
NEW YORK, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/19/2000

Market Cap

209,156,265

Shares Outstanding

22,050,000

Weighted SO

22,046,101

Total Employees

N/A

Upcoming Earnings

08/14/2024

Beta

0.6420

Last Div

0.0000

Range

2.25-9.18

Chg

-0.0200

Avg Vol

249738

Mkt Cap

209156265

Exch

NASDAQ

Country

US

Phone

212 489 2100

DCF Diff

11.9697

DCF

-4.4896

Div Yield

0.0000

P/S

17.6087

EV Multiple

-5.5729

P/FV

50.5450

Div Yield %

0.0000

P/E

-3.7616

PEG

-0.2658

Payout

0.0000

Current Ratio

2.5546

Quick Ratio

2.0408

Cash Ratio

1.2027

DSO

115.2033

DIO

833.1550

Op Cycle

948.3584

DPO

432.5389

CCC

515.8195

Gross Margin

0.7670

Op Margin

-3.0350

Pretax Margin

-4.7422

Net Margin

-4.7422

Eff Tax Rate

0.0311

ROA

-1.6610

ROE

-3.7990

ROCE

-1.6673

NI/EBT

1.0000

EBT/EBIT

1.5625

EBIT/Rev

-3.0350

Debt Ratio

0.1646

D/E

1.3318

LT Debt/Cap

0.1909

Total Debt/Cap

0.5712

Int Coverage

122.2034

CF/Debt

-5.6196

Equity Multi

8.0899

Rec Turnover

3.1683

Pay Turnover

0.8439

Inv Turnover

0.4381

FA Turnover

4.7247

Asset Turnover

0.3502

OCF/Share

-1.1061

FCF/Share

-1.1107

Cash/Share

0.7018

OCF/Sales

-2.6414

FCF/OCF

1.0042

CF Coverage

-5.6196

ST Coverage

-6.8293

CapEx Coverage

-237.6818

Div&CapEx Cov

-237.6818

P/BV

50.5450

P/B

50.5450

P/S

17.6087

P/E

-3.7616

P/FCF

-6.6386

P/OCF

-6.7535

P/CF

-6.7535

PEG

-0.2658

P/S

17.6087

EV Multiple

-5.5729

P/FV

50.5450

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation